Basic Fibroblast Growth Factor Attenuates Injury in Myocardial Infarction by Enhancing Hypoxia-Inducible Factor-1 Alpha Accumulation

BACKGROUND: The combination of antiapoptotic and angiogenic actions may represent a pharmacotherapeutic strategy for the treatment of myocardial infarction. Fibroblast growth factor (FGF) is expressed in various cell types including endothelial and muscle cells and promotes their survival, migration...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Zhiheng, Shen, Danping, Chen, Jiahui, Jin, Lushen, Wu, Xueping, Chen, Ming, Li, Lei, Chu, Maoping, Lin, Jiafeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427464/
https://www.ncbi.nlm.nih.gov/pubmed/32848793
http://dx.doi.org/10.3389/fphar.2020.01193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427464/
https://www.ncbi.nlm.nih.gov/pubmed/32848793
http://dx.doi.org/10.3389/fphar.2020.01193

Ejemplares similares